Novel anti-DC-SIGN antibodies

摘要

The present invention relates to an antibody for use in treating cancer, wherein the antibody binds to DC-SIGN on the surface of a cancer cell and wherein the binding of the antibody to a DC-SIGN-expressing cancer cell kills the cancer cell. Furthermore, the invention relates to an antibody for use in treating an inflammatory disease or an autoimmune disease, wherein the antibody binds to DC-SIGN on the surface of a dendritic cell and wherein the binding of the antibody to a DC-SIGN-expressing dendritic cell kills the dendritic cell.